- Home
- CISO vs DRRX Comparison
CISO vs DRRX Comparison
Compare CISO & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- DRRX
- Stock Information
- Founded
- CISO 2015
- DRRX 1998
- Country
- CISO United States
- DRRX United States
- Employees
- CISO N/A
- DRRX N/A
- Industry
- CISO Computer Software: Prepackaged Software
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- DRRX Health Care
- Exchange
- CISO Nasdaq
- DRRX Nasdaq
- Market Cap
- CISO 32.7M
- DRRX 26.4M
- IPO Year
- CISO N/A
- DRRX 2000
- Fundamental
- Price
- CISO $1.03
- DRRX $0.85
- Analyst Decision
- CISO
- DRRX Buy
- Analyst Count
- CISO 0
- DRRX 2
- Target Price
- CISO N/A
- DRRX $5.00
- AVG Volume (30 Days)
- CISO 312.9K
- DRRX 124.4K
- Earning Date
- CISO 11-18-2024
- DRRX 11-13-2024
- Dividend Yield
- CISO N/A
- DRRX N/A
- EPS Growth
- CISO N/A
- DRRX N/A
- EPS
- CISO N/A
- DRRX N/A
- Revenue
- CISO $54,633,909.00
- DRRX $8,594,000.00
- Revenue This Year
- CISO $78.76
- DRRX $54.32
- Revenue Next Year
- CISO N/A
- DRRX N/A
- P/E Ratio
- CISO N/A
- DRRX N/A
- Revenue Growth
- CISO 34.87
- DRRX N/A
- 52 Week Low
- CISO $0.26
- DRRX $0.68
- 52 Week High
- CISO $3.84
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- CISO 36.83
- DRRX 47.88
- Support Level
- CISO $0.93
- DRRX $0.79
- Resistance Level
- CISO $1.39
- DRRX $0.86
- Average True Range (ATR)
- CISO 0.51
- DRRX 0.08
- MACD
- CISO -0.19
- DRRX 0.01
- Stochastic Oscillator
- CISO 3.30
- DRRX 51.69
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .